Investors are buying the shares that have performed the best this year. It's a typical year-end rally.
Investors want to show they're in the best positions in their end-of-year fund reports.
Sentiment is very good. We're seeing a last run as investors buy up shares that have done well during the year.
Selling the drug unit is going to focus the company. The earnings were also better than expected. It is a good day for investors.
Earnings continue to come in above market expectations. Takeover speculation is also fueling demand, so the market just continues to rise.
We are now seeing a clear improvement in the European economy, and that should pave the way for stocks. Growth should have a nice effect on earnings this year.
Stocks are very sensitive to the risk of interest rates rising further. Higher borrowing costs can affect the ability of companies to expand and for consumers to spend.
Stocks are very sensitive to the risk of interest rates rising further. Financial institutions are especially vulnerable.
The earnings evolution is definitely slowing in Europe. Combined with rising interest rates and an excellent performance over the last few months, we can expect the market to take a pause.
